BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25077421)

  • 1. Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice.
    Mosolygó T; Szabó AM; Balogh EP; Faludi I; Virók DP; Endrész V; Samu A; Krenács T; Burián K
    Vaccine; 2014 Sep; 32(40):5228-33. PubMed ID: 25077421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Chlamydia muridarum plasmid genes and immunogenicity of pGP3 and pGP4 in different mouse strains.
    Mosolygó T; Faludi I; Balogh EP; Szabó ÁM; Karai A; Kerekes F; Virók DP; Endrész V; Burián K
    Int J Med Microbiol; 2014 May; 304(3-4):476-83. PubMed ID: 24631212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
    Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
    Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genital Tract Virulence Factor pGP3 Is Essential for Chlamydia muridarum Colonization in the Gastrointestinal Tract.
    Shao L; Zhang T; Melero J; Huang Y; Liu Y; Liu Q; He C; Nelson DE; Zhong G
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
    Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
    J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice.
    Cunningham KA; Carey AJ; Timms P; Beagley KW
    Vaccine; 2010 Jul; 28(31):4861-3. PubMed ID: 20653101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice.
    Liu Y; Huang Y; Yang Z; Sun Y; Gong S; Hou S; Chen C; Li Z; Liu Q; Wu Y; Baseman J; Zhong G
    Infect Immun; 2014 Dec; 82(12):5327-35. PubMed ID: 25287930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Plasmid-Encoded pGP3 Promotes
    Zhang T; Huo Z; Ma J; He C; Zhong G
    Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30858342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
    Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
    Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice.
    Zhao L; Wang X; Li Z
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128723. PubMed ID: 38101679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence Protein Pgp3 Is Insufficient To Mediate Plasmid-Dependent Infectivity of Chlamydia trachomatis.
    Turman BJ; Alzhanov D; Nagarajan UM; Darville T; O'Connell CM
    Infect Immun; 2023 Feb; 91(2):e0039222. PubMed ID: 36722979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
    Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
    PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
    Li W; Murthy AK; Lanka GK; Chetty SL; Yu JJ; Chambers JP; Zhong G; Forsthuber TG; Guentzel MN; Arulanandam BP
    Vaccine; 2013 Nov; 31(48):5722-8. PubMed ID: 24096029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
    Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.